Dr. Refky Nicola speaks with Dr. Atul Shinagare about his team's research showing that incidental adnexal lesions on single‑phase CT are often difficult for radiologists to classify consistently, with only certain classic lesions yielding strong agreement. Their conversation underscores the limitations of CT compared with ultrasound or MRI and reinforces that most incidental adnexal findings are benign, though many still require additional imaging for clarification.

Imaging in Advanced Epithelial Ovarian Cancer: Assessment of Peritoneal Spread. Nougaret and Lakhman et al. Radiology 2026; 318(3):e250116.

Dr. Ashwin Parihar speaking with Drs. Sungmin Woo and Alberto Vargas about why standardized PSMA PET scoring systems—such as PSMA‑RADS and PROMISE—are becoming essential for consistent interpretation, communication, and treatment planning in prostate cancer. They explore the evidence behind these frameworks, current barriers to adoption, and how future harmonization efforts like the SPARC Initiative may shape the evolution of PSMA PET reporting.

Navigating the Scoring Systems and Interpretation Frameworksof Prostate-specific Membrane Antigen PET. Woo and Masci et al. Radiology 2025; 317(3):e250701.

Dr. Lauren Kim speaks with Adarsh Mallepady and Dr. Cory Trankle about their large-scale retrospective study of nearly 4 million patients examining the risk of nephrogenic systemic fibrosis after gadolinium-based contrast administration in those with advanced renal dysfunction. They discuss how modern group 2 and macrocyclic agents were associated with an exceedingly low incidence of NSF, offering important reassurance for evidence-based contrast use and evolving clinical practice.

Nephrogenic Systemic Fibrosis in Patients with Advanced RenalDysfunction Following Gadolinium-based Contrast Agents. Mallepally et al. Radiology 2025; 317(3):e251794.